(S)-1-(4-isopropylphenyl)ethan-1-amine, 98%, 100mg

Periodate de sodium, min 99,8 %, pa, ACS, 250 g, emballage plastique.

5-[(2R)-pyrrolidin-2-yl]-1H-1,2,3,4-tetrazole hydrochloride, 95%, 100g

1-(6,7-Dichloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)ethanone, 95.0%, 250mg

R-(-)-3-Fluoropyrrolidine hydrochloride, 98.0%, 1g

Spiro[indene-2,4'-piperidin]-1(3H)-one hydrochloride, 95.0%, 100mg

Palmitate d'isopropyle, min 90 %, pour la synthèse, 1 l, emballage plastique.

4-Chloro-2-fluorobenzamide, 95.0%, 1g

3-Propyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-one, 97.0%, 50mg

2-Fluoro-4-(methylsulfonyl)-1-nitrobenzene, 95.0%, 10g

2-(Cyclohex-1-enylamino)benzoic acid, 95.0%, 10g

methyl 4-(2-bromoethoxy)-3-chlorobenzoate, 95.0%, 1g

1-Methyl-2-(methylsulfonyl)-1H-benzo[d]imidazole, 98%, 1g